Oncolytics Biotech (ONCY) Non-cash Items (2009 - 2010)
Oncolytics Biotech (ONCY) posted quarterly Non-cash Items of $16.1 million for Q4 2010, up 29.94% year-over-year from $12.4 million in Q4 2009, and up 423.32% quarter-over-quarter from -$5.0 million in Q3 2010.
Oncolytics Biotech (ONCY) Non-cash Items (2009 - 2010) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Non-cash Items for 2 consecutive years, with $16.1 million the latest figure, recorded in Q4 2010.
- In Q4 2010, Non-cash Items rose 29.94% year-over-year to $16.1 million; the TTM figure through Dec 2010 stood at $148.3 million (up 662.16% YoY), while the FY2010 annual figure was $1.8 million, up 1558.99% from the prior year.
- Non-cash Items advanced to $16.1 million in Q4 2010 per ONCY's latest filing, from -$5.0 million in the prior quarter.
- Across five years, Non-cash Items topped out at $136.8 million in Q2 2010 and bottomed at -$5.0 million in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oncolytics Biotech | 101.16 Mn | 101.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 16.06 Mn |
| Dec 31, 2010 | 16.06 Mn |
| Sep 30, 2010 | -4.97 Mn |
| Sep 30, 2010 | -4.97 Mn |
| Jun 30, 2010 | 136.82 Mn |
| Jun 30, 2010 | 136.82 Mn |
| Mar 31, 2010 | 363,895.00 |
| Mar 31, 2010 | 363,895.00 |
| Dec 31, 2009 | 12.36 Mn |
| Dec 31, 2009 | 12.36 Mn |
| Sep 30, 2009 | -2.61 Mn |
| Sep 30, 2009 | -2.61 Mn |
| Jun 30, 2009 | 8.32 Mn |
| Jun 30, 2009 | 8.32 Mn |
| Mar 31, 2009 | 1.38 Mn |
| Mar 31, 2009 | 1.38 Mn |